Scoparone can ameliorate liver inflammation and enhance autophagy in NASH mice by inhibiting the ROS/P38/Nrf2 axis and PI3K/AKT/mTOR pathway, thereby promoting autophagic flux while suppressing inflammation. This evidence concerns the gene AKT1 and metabolic dysfunction-associated steatohepatitis.